146 related articles for article (PubMed ID: 15036190)
1. Clinical risk score correlates with yield of PET scan in patients with colorectal hepatic metastases.
Schüssler-Fiorenza CM; Mahvi DM; Niederhuber J; Rikkers LF; Weber SM
J Gastrointest Surg; 2004 Feb; 8(2):150-7; discussion 157-8. PubMed ID: 15036190
[TBL] [Abstract][Full Text] [Related]
2. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study.
Ruers TJ; Langenhoff BS; Neeleman N; Jager GJ; Strijk S; Wobbes T; Corstens FH; Oyen WJ
J Clin Oncol; 2002 Jan; 20(2):388-95. PubMed ID: 11786565
[TBL] [Abstract][Full Text] [Related]
3. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).
Fernandez FG; Drebin JA; Linehan DC; Dehdashti F; Siegel BA; Strasberg SM
Ann Surg; 2004 Sep; 240(3):438-47; discussion 447-50. PubMed ID: 15319715
[TBL] [Abstract][Full Text] [Related]
4. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases.
Fong Y; Saldinger PF; Akhurst T; Macapinlac H; Yeung H; Finn RD; Cohen A; Kemeny N; Blumgart LH; Larson SM
Am J Surg; 1999 Oct; 178(4):282-7. PubMed ID: 10587184
[TBL] [Abstract][Full Text] [Related]
5. Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study.
Strasberg SM; Dehdashti F; Siegel BA; Drebin JA; Linehan D
Ann Surg; 2001 Mar; 233(3):293-9. PubMed ID: 11224615
[TBL] [Abstract][Full Text] [Related]
6. The influence of FDG PET-CT on the detection of extrahepatic disease in patients being considered for resection of colorectal liver metastasis.
Lake ES; Wadhwani S; Subar D; Kauser A; Harris C; Chang D; Lapsia S
Ann R Coll Surg Engl; 2014 Apr; 96(3):211-5. PubMed ID: 24780786
[TBL] [Abstract][Full Text] [Related]
7. Preoperative positron emission tomography to evaluate potentially resectable hepatic colorectal metastases.
Joyce DL; Wahl RL; Patel PV; Schulick RD; Gearhart SL; Choti MA
Arch Surg; 2006 Dec; 141(12):1220-6; discussion 1227. PubMed ID: 17178965
[TBL] [Abstract][Full Text] [Related]
8. A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases.
Jarnagin WR; Conlon K; Bodniewicz J; Dougherty E; DeMatteo RP; Blumgart LH; Fong Y
Cancer; 2001 Mar; 91(6):1121-8. PubMed ID: 11267957
[TBL] [Abstract][Full Text] [Related]
9. Does positron emission tomography/computed tomography change management in colorectal cancer?
Falconer R; Connor S; Balasingam A; Eglinton T
ANZ J Surg; 2018 Apr; 88(4):E248-E251. PubMed ID: 27788564
[TBL] [Abstract][Full Text] [Related]
10. The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer.
Rohren EM; Paulson EK; Hagge R; Wong TZ; Killius J; Clavien PA; Nelson RC
Clin Nucl Med; 2002 Aug; 27(8):550-5. PubMed ID: 12169999
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of positron emission tomography for predicting chemotherapy response in colorectal cancer liver metastases.
Glazer ES; Beaty K; Abdalla EK; Vauthey JN; Curley SA
Arch Surg; 2010 Apr; 145(4):340-5; discussion 345. PubMed ID: 20404283
[TBL] [Abstract][Full Text] [Related]
12. Resection of liver metastases from colorectal cancer: does preoperative chemotherapy affect the accuracy of PET in preoperative planning?
Adie S; Yip C; Chu F; Morris DL
ANZ J Surg; 2009 May; 79(5):358-61. PubMed ID: 19566517
[TBL] [Abstract][Full Text] [Related]
13. Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial.
Moulton CA; Gu CS; Law CH; Tandan VR; Hart R; Quan D; Fairfull Smith RJ; Jalink DW; Husien M; Serrano PE; Hendler AL; Haider MA; Ruo L; Gulenchyn KY; Finch T; Julian JA; Levine MN; Gallinger S
JAMA; 2014 May; 311(18):1863-9. PubMed ID: 24825641
[TBL] [Abstract][Full Text] [Related]
14. The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver.
Boykin KN; Zibari GB; Lilien DL; McMillan RW; Aultman DF; McDonald JC
Am Surg; 1999 Dec; 65(12):1183-5. PubMed ID: 10597072
[TBL] [Abstract][Full Text] [Related]
15. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.
Wiering B; Krabbe PF; Jager GJ; Oyen WJ; Ruers TJ
Cancer; 2005 Dec; 104(12):2658-70. PubMed ID: 16315241
[TBL] [Abstract][Full Text] [Related]
16. The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver.
Lai DT; Fulham M; Stephen MS; Chu KM; Solomon M; Thompson JF; Sheldon DM; Storey DW
Arch Surg; 1996 Jul; 131(7):703-7. PubMed ID: 8678767
[TBL] [Abstract][Full Text] [Related]
17. The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings.
Lubezky N; Metser U; Geva R; Nakache R; Shmueli E; Klausner JM; Even-Sapir E; Figer A; Ben-Haim M
J Gastrointest Surg; 2007 Apr; 11(4):472-8. PubMed ID: 17436132
[TBL] [Abstract][Full Text] [Related]
18. FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma.
Willkomm P; Bender H; Bangard M; Decker P; Grünwald F; Biersack HJ
J Nucl Med; 2000 Oct; 41(10):1657-63. PubMed ID: 11037995
[TBL] [Abstract][Full Text] [Related]
19. Trends in nontherapeutic laparotomy rates in patients undergoing surgical therapy for hepatic colorectal metastases.
Pawlik TM; Assumpcao L; Vossen JA; Buijs M; Gleisner AL; Schulick RD; Choti MA
Ann Surg Oncol; 2009 Feb; 16(2):371-8. PubMed ID: 19020939
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer patients before resection of hepatic metastases. Impact of (18)F-FDG PET on detecting extrahepatic disease.
Rosa F; Meimarakis G; Stahl A; Bumm R; Hahn K; Tatsch K; Dresel S
Nuklearmedizin; 2004 Aug; 43(4):135-40. PubMed ID: 15316581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
